Small Molecules in Hematology

Nonfiction, Health & Well Being, Medical, Specialties, Internal Medicine, Hematology, Oncology
Cover of the book Small Molecules in Hematology by , Springer International Publishing
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9783319914398
Publisher: Springer International Publishing Publication: August 1, 2018
Imprint: Springer Language: English
Author:
ISBN: 9783319914398
Publisher: Springer International Publishing
Publication: August 1, 2018
Imprint: Springer
Language: English

This book, written by respected experts, discusses in detail the latest developments in targeted therapy for hematologic malignancies using small molecules. It covers a wide range of small molecules including tyrosine kinase inhibitors, immunomodulatory drugs, the IDH-2 inhibitor enasidenib, the BCL-2 inhibitor venetoclax, and the proteasome inhibitor carfilzomib. For each molecule, aspects such as the chemical structure, mechanism of action, drug targets, drug interactions, preclinical studies, clinical trials, treatment applications, and toxicity are discussed. 

Extensive research into the molecular mechanisms of cancer has heralded a new age of targeted therapy. The field of precision cancer therapy is now growing rapidly, and the advances being made will mean significant changes in the treatment algorithms for cancer patients. Numerous novel targets that are crucial for the survival of cancer cells can be attacked by small molecules such as protein tyrosine kinase inhibitors. An accompanying volume addresses the use of small molecules in oncology, and the two volumes together represent the third edition of the book originally published under the same title. 

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

This book, written by respected experts, discusses in detail the latest developments in targeted therapy for hematologic malignancies using small molecules. It covers a wide range of small molecules including tyrosine kinase inhibitors, immunomodulatory drugs, the IDH-2 inhibitor enasidenib, the BCL-2 inhibitor venetoclax, and the proteasome inhibitor carfilzomib. For each molecule, aspects such as the chemical structure, mechanism of action, drug targets, drug interactions, preclinical studies, clinical trials, treatment applications, and toxicity are discussed. 

Extensive research into the molecular mechanisms of cancer has heralded a new age of targeted therapy. The field of precision cancer therapy is now growing rapidly, and the advances being made will mean significant changes in the treatment algorithms for cancer patients. Numerous novel targets that are crucial for the survival of cancer cells can be attacked by small molecules such as protein tyrosine kinase inhibitors. An accompanying volume addresses the use of small molecules in oncology, and the two volumes together represent the third edition of the book originally published under the same title. 

More books from Springer International Publishing

Cover of the book Marine Isotope Stage 3 in Southern South America, 60 KA B.P.-30 KA B.P. by
Cover of the book Nano-Publics by
Cover of the book Fuzzy Systems & Operations Research and Management by
Cover of the book Escalation of Commitment in Internationalization Processes by
Cover of the book Parental Responsibility in the Context of Neuroscience and Genetics by
Cover of the book Nanoscience in Food and Agriculture 3 by
Cover of the book Sunspots and Non-Linear Dynamics by
Cover of the book Teaching about Technology by
Cover of the book Bifurcation without Parameters by
Cover of the book Adsorption Processes for Water Treatment and Purification by
Cover of the book High Resolution Palaeoclimatic Changes in Selected Sectors of the Indian Himalaya by Using Speleothems by
Cover of the book Nordic Law in European Context by
Cover of the book A History of Folding in Mathematics by
Cover of the book The Work and Play of the Mind in the Information Age by
Cover of the book Cross-Cultural Perspectives on Couples with Mixed HIV Status: Beyond Positive/Negative by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy